Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChemring Regulatory News (CHG)

Share Price Information for Chemring (CHG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 390.50
Bid: 391.50
Ask: 392.00
Change: 6.50 (1.69%)
Spread: 0.50 (0.128%)
Open: 391.00
High: 392.00
Low: 383.50
Prev. Close: 384.00
CHG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Disposal of Chemring Ordnance

21 Nov 2019 07:00

RNS Number : 1805U
Chemring Group PLC
21 November 2019
 

 

FOR IMMEDIATE RELEASE 21 November 2019

CHEMRING GROUP PLC ("Chemring" or the "Group")

Disposal of Chemring Ordnance, Inc.

Chemring today announces that a conditional agreement has been entered into for the sale of its US subsidiary Chemring Ordnance, Inc. ("COR") to Nammo Defense Systems Inc. ("Nammo") for a cash consideration of $17 million. This sale completes the Group's exit from its commoditised energetics businesses.

The sale, which is subject to regulatory approval by the US authorities, is expected to complete no later than the end of Q2 FY20.

COR, located in Perry, Florida, manufactures a range of ordnance and pyrotechnic products primarily for military customers. In the year ended 31 October 2018, COR generated revenue of $57 million, an underlying operating loss of $0.2 million, had gross assets of $20.5 million and net assets of $11.3 million. The business was treated as discontinued in the Group's 2018 financial statements and for the year ended 31 October 2019 made a small operating loss.

The consideration will be paid in cash on completion, subject to a working capital adjustment.

The proceeds after costs will be used by the Group for general corporate purposes.

Nammo is an international aerospace and defence company headquartered in Norway. With 2,400 employees across more than 30 sites and offices in 13 countries, the company is one of the world's leading providers of ammunition and rocket motors for both military and civilian customers.

Following a strategic review, the Group announced in November 2018 its intention to exit the commoditised energetics businesses located in Derby and Florida, and to focus on its niche specialist energetic devices and materials businesses in Chicago, Scotland and Norway, where the Group has strong intellectual property and high barriers to entry.

Michael Ord, Chief Executive of Chemring, said:

"I am pleased to announce the sale of Chemring Ordnance to Nammo. This transaction is another step in the delivery of our strategy and provides a greater focus on our growing and differentiated positions in Sensors & Information and Countermeasures & Energetics. Today's announcement concludes the process of exiting the Group's commoditised energetics businesses and further improves the quality of the Group and its future earnings."

- ENDS -

 

 

For further information:

Rupert Pittman

Group Director of Corporate Affairs, Chemring Group PLC

+44 (0)1794 833901

Andrew Jaques

Oliver Hughes

MHP Communications

+44 (0)20 3128 8100

Notes to editors

1. In November 2018 the Group announced that the future focus of its Energetics segment would be on its niche energetic devices and materials businesses in Chicago, Scotland and Norway. The Group also announced it would exit the commoditised energetics businesses in Derby and Florida; these businesses were treated as discontinued in the 2018 financial statements. In April 2019 the Group announced the sale of Chemring Military Products in Florida, and in June 2019 the Group announced the sale of Chemring Defence in Derby.

 

2. About Chemring

·; Chemring is a global business that specialises in the manufacture of high technology products and the provision of services to the aerospace, defence and security markets

·; Employing approximately 2,500 people worldwide, and with production facilities in four countries, Chemring meets the needs of customers in more than fifty countries

·; Chemring is now organised under two strategic product segments: Countermeasures & Energetics, and Sensors & Information

·; Chemring has a diverse portfolio of products that deliver high reliability solutions to protect people, platforms, missions and information against constantly changing threats

·; Operating in niche markets and with strong investment in research and development, Chemring has the agility to rapidly react to urgent customer needs

www.chemring.co.uk

 Cautionary statement

This announcement contains unaudited information based on management accounts and forward-looking statements that are based on current expectations or beliefs, as well as assumptions about future events. These forward-looking statements can be identified by the fact that they do not relate only to historical or current facts. Forward-looking statements often use words such as anticipate, target, expect, estimate, intend, plan, goal, believe, will, may, should, would, could, is confident, or other words of similar meaning. Undue reliance should not be placed on any such statements because they speak only as at the date of this document and, by their very nature, they are subject to known and unknown risks and uncertainties and can be affected by other factors that could cause actual results, and Chemring's plans and objectives, to differ materially from those expressed or implied in the forward-looking statements.

There are a number of factors which could cause actual results to differ materially from those expressed or implied in forward-looking statements. Among the factors that could cause actual results to differ materially from those described in the forward-looking statements are; increased competition, the loss of or damage to one or more key customer relationships, changes to customer ordering patterns, delays in obtaining customer approvals for engineering or price level changes, the failure of one or more key suppliers, the outcome of business or industry restructuring, the outcome of any litigation, changes in economic conditions, currency fluctuations, changes in interest and tax rates, changes in raw material or energy market prices, changes in laws, regulations or regulatory policies, developments in legal or public policy doctrines, technological developments, the failure to retain key management, or the key timing and success of future acquisition opportunities or major investment projects.

Chemring undertakes no obligation to revise or update any forward-looking statement contained within this announcement, regardless of whether those statements are affected as a result of new information, future events or otherwise, save as required by law and regulations.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DISMMMZMKMKGLZG
Date   Source Headline
1st May 202411:29 amRNSTotal Voting Rights
22nd Apr 20247:00 amRNSTransaction in Own Shares
19th Apr 20247:00 amRNSTransaction in Own Shares
18th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSTransaction in Own Shares
11th Apr 20247:00 amRNSTransaction in Own Shares
10th Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 20249:13 amRNSTotal Voting Rights
26th Mar 20247:00 amRNSTransaction in Own Shares
25th Mar 20247:00 amRNSDirector/PDMR Shareholding
25th Mar 20247:00 amRNSDirector/PDMR Shareholding
18th Mar 20247:00 amRNSFunding Awards
18th Mar 20247:00 amRNSTransaction in Own Shares
15th Mar 20247:00 amRNSTransaction in Own Shares
14th Mar 20247:00 amRNSTransaction in Own Shares
13th Mar 20247:00 amRNSTransaction in Own Shares
12th Mar 20247:00 amRNSTransaction in Own Shares
6th Mar 20247:00 amRNSTransaction in Own Shares
4th Mar 20247:00 amRNSTransaction in Own Shares
1st Mar 20247:00 amRNSTransaction in Own Shares
1st Mar 20247:00 amRNSTotal Voting Rights
29th Feb 20247:00 amRNSTransaction in Own Shares
28th Feb 20247:00 amRNSTransaction in Own Shares
26th Feb 20247:00 amRNSTransaction in Own Shares
23rd Feb 202412:45 pmRNSResult of AGM
23rd Feb 20247:00 amRNSAGM Update
16th Feb 20247:00 amRNSTransaction in Own Shares
14th Feb 20247:00 amRNSTransaction in Own Shares
9th Feb 20247:00 amRNSTransaction in Own Shares
5th Feb 20247:00 amRNSTransaction in Own Shares
2nd Feb 20248:09 amRNSTransaction in Own Shares
1st Feb 20249:59 amRNSTotal Voting Rights
26th Jan 20247:00 amRNSTransaction in Own Shares
25th Jan 20247:00 amRNSTransaction in Own Shares
24th Jan 20247:00 amRNSTransaction in Own Shares
22nd Jan 20247:00 amRNSTransaction in Own Shares
19th Jan 20247:00 amRNSTransaction in Own Shares
18th Jan 20247:00 amRNSTransaction in Own Shares
17th Jan 20247:00 amRNSTransaction in Own Shares
16th Jan 20247:00 amRNSDirector/PDMR Shareholding
16th Jan 20247:00 amRNSTransaction in Own Shares
15th Jan 20244:16 pmRNSNotice of AGM
15th Jan 20247:00 amRNSTransaction in Own Shares
12th Jan 20241:11 pmRNSHolding(s) in Company
12th Jan 20247:00 amRNSTransaction in Own Shares
11th Jan 20247:00 amRNSTransaction in Own Shares
10th Jan 20247:00 amRNSTransaction in Own Shares
9th Jan 20247:00 amRNSTransaction in Own Shares
8th Jan 20242:27 pmRNSHolding(s) in Company (Corrected)
8th Jan 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.